David Rubert

I co-lead regional strategy for Nucleate’s emerging chapters across Europe. That means turning Nucleate’s global strategy into country-level plans and guiding new chapter leadership teams from launch to sustainable growth. I’m part of Nucleate’s global team. - Co-lead and coach the Co-Managing Directors of 7 emerging chapters (Spain, Italy, France, Belgium, the Netherlands, Sweden, Norway), setting goals and checkpoints for team building, strategy, communications and programme launch. - Co-own the interfa

By accelerating the path from sample to result, we drive earlier detection, more confident decisions, and stronger outcomes, making a real impact from discovery to patient care and beyond. Leading global marketing end-to-end, GTM and business development strategy for next-generation molecular diagnostics across clinical, research, field, and public health applications. Acting as the bridge between R&D, sales, I align product development with market needs to deliver impactful, validated solutions. - Own an

Invited annually to deliver a guest lecture to Master’s students on scientific career paths, the transition from academia to industry and the value of non-profit organizations engagement.

- Led launches and GTM strategy for 6 key products, expanding the IVD and POC portfolio by 17% and driving adoption across international markets. - Built a demand engine: 15+ targeted campaigns to 100K+ professionals across 30+ countries, >35% open rate, >30% CTR. - Scaled brand visibility worldwide with 1300+ new LinkedIn followers in 1 year and 3× engagement through integrated storytelling and event-led marketing. Managed and ran GoogleAds. - Executed 8 global webinars: 1.2K+ participants, generating h

Co-lead a cross-functional and diverse team of 10+ members across 4 regional chapters (Munich, Berlin, Heidelberg, Cologne) to drive early-stage biotech innovation across Germany through our start-up accelerator program, the Activator, Nucleate's flagship equity-free startup accelerator. I oversee the team and guide them thought the scouting, evaluation, and support of academic spinouts and life science startups, conducting due diligence, building mentor and investor networks, and connecting founders with s

Owned Nucleate Germany's brand, communications, and community presence, building the channels, content, and events that grew national visibility across the German biotech ecosystem. - Grew the LinkedIn channel by +1,500 followers in 7 months (~215/month) and launched the Nucleate Germany newsletter, now reaching 1,500+ readers every month. - Built a streamlined Notion-based communications system that standardized tools and workflows, driving fast team adoption and consistent output across the chapter. -

Nucleate is a global non-profit organization that empowers the next generation of biotech leaders and facilitates the formation of pioneering biotech companies. Through regular events, we unite the biotech community, creating opportunities for collaboration and innovation. Our accelerator program, the Activator, provides early-stage companies with invaluable insights from industry experts, investors, and founders, guiding them on their entrepreneurial journey and equipping them with the tools to succeed.

3rd and 4th year of the PhD program. - Completed the final experiments for the ERC-funded project "Ribolife" (1.5 Milion € funding) - Published the comprehensive findings as a doctoral dissertation. - Effectively managed multiple projects, analyzed data, identified issues and solutions, conducted literature mining, and presented monthly. - Collaborated with the research group to relocate, establish, and oversee operations of the new labs at TU Dortmund. - Mentored and trained students and new collegue

1st and 2nd year of the PhD program. - Led the development and validation of molecular technologies for constructing modular and centric synthetic RNA genomes within synthetic cells as part of the European Union Council-funded project 'Ribolife'. - Initiated the PhD project by conducting comprehensive literature mining and establishing project targets. - Actively participated in entrepreneurship workshops at TUM and Young Entrepreneurs in Science in Munich. Actively participating and getting involved in

- Designed and executed extensive experiments for the industrial funded project focused on validating the effects of pathway relocation on cellular function and energy production performance on industrial yeast strains. - Analyzed data and identified system improvements: enhanced protein production yields. - Alongside the scientific tasks, coordinated group activities for the international Erasmus group, facilitating collaboration among diverse members to foster unity and cross-cultural understanding and

MSc project - Biocatalysis and Cyanobacteria group (prof. Bergantino). - Explored new genetic engineering tools for the design, construction and optimization of novel cell-factories for whole-cell photobiocatalysis in the cyanobacteria Synechocystis PCC6803, followed by strain characterization. - Co-authored a scientific paper based on the project. - Demonstrated excellent project and time management skills, earning a cum laude final evaluation. - Collaborated with three research groups to establish the

BSc project - Non-coding RNA and Genomic Stability group. - Developed a protocol to quantify lncRNA transcription in mammalian cells, uncover its role in cancer progression, detect TERRA lncRNAs in cancer cells, and investigate their molecular mechanisms and impact on cancer development. - Collaborated with an international team of senior researchers at a top-tier cancer research institution, quickly assimilating and applying their feedback to lead the development of this detection tool. - Developed expe

- Topics: databases, SQL, spreadsheets and Tableau, Python (Pandas and Seaborn), Machine Learning, AI.

3rd and 4th year of the PhD program. - Thesis: “Towards the design and construction of self-replicating RNA nanostructures” – Supervised by Prof. Dr. Hannes Mutschler

- Project: “Metabolic engineering of Saccharomyces cerevisiae TCA cycle for improved energy generation” – Supervised by Prof. Dr. Jack Pronk.

1st and 2nd year of PhD programme.

- Thesis: “Design and construction of synthetic biology toolboxes for the engineering of Synechocystis sp. PCC6803 as photosynthetic cell-factory”. - Supervised by Prof. Dr. Elisabetta Bergantino. - The program emphasized innovation in healthcare technologies, medical imaging, and the development

- Thesis: “Quantification of telomeric lncRNAs TERRA by qPCR in U2OS ALT positive cancer cells”. - Supervised by Prof. Dr. Stefan Schoeftner. - The program focused on biomedical subjects such as pharmacology, physiology, drug kinetics, immunology, oncology, molecular pathology, and molecular biolo